RSS   Newsletter   Contact   Advertise with us

Wilson Therapeutics appoints Anders Martin-Lof as CFO

Staff writer | Stockholm, Sweden | November 4, 2015
Wilson TherapeuticsNovember 4, 2015, Stockholm, Sweden - Wilson Therapeutics AB, a privately-held biopharmaceutical company, announced the appointment of Anders Martin-Löf as chief financial officer.
Mr. Martin-Löf will join the company’s management team. Mr. Martin-Löf has more than 15 years’ experience in the life science sector and has held a number of management positions in finance, investor relations and business development. Most recently, he served as CFO of Extenda, a privately-held software company.

Before joining Extenda, he was the CFO of RaySearch Laboratories AB, a medical technology company that develops advanced software solutions for radiation therapy of cancer and is listed on NASDAQ OMX Stockholm.

Prior to joining RaySearch, Mr. Martin-Löf served as Director of Investor Relations and held various business development positions for the biotech company Biovitrum (SOBI).

Before that, he was a management consultant at the Boston Consulting Group, Cell Network and co-founder and CEO of ScienceCap, a consulting firm focused on small-cap companies in the biotech and medtech sectors.

Mr. Martin-Löf holds a M.Sc. in Engineering Physics from the Royal Institute of Technology and a B.Sc in Business Administration and Economics from Stockholm University.